Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis

Published:2014-04-22 Issue:1 Volume:22 Page:215-218
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Tortelli R.¹²,Copetti M.³,Ruggieri M.¹,Cortese R.¹,Capozzo R.¹,Leo A.¹,D'Errico E.¹,Mastrapasqua M.¹,Zoccolella S.¹,Pellegrini F.³,Simone I. L.¹,Logroscino G.¹²

Affiliation:

1. Department of Basic Medical Science; Neuroscience and Sense Organs; University of Bari; Bari Italy

2. Department of Clinical Research in Neurology; Unit of Neurodegenerative Diseases; University of Bari, c/o Pia Fondazione Card. G. Panico; Tricase (Lecce) Italy

3. Unit of Biostatistics; IRCCS ‘Casa Sollievo della Sofferenza’ Hospital; San Giovanni Rotondo; Italy

Funder

Progetto Ordinario Regione Puglia from the Italian Ministry of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12421/fullpdf

Reference13 articles.

1. Axonal damage markers in cerebrospinal fluid are increased in ALS;Brettschneider;Neurology,2006

2. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype;Zetterberg;Eur J Neurol,2007